Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Is print the new vinyl?

The release of the National Medical Readership Survey prompts the inevitable discussion about the role of print vs. other channels in the marketing mix, when targeting GPs and HCPs generally...

- PMLiVE

FDA approves Synergy’s constipation drug Trulance

Set to launch by March this year, analysts say the CIC therapy could see sales of $450m by 2020

Bristol-Myers Squibb (BMS) building

BMS won’t seek quick okay for Opdivo combo in lung cancer

No longer intends to file for accelerated approval, pushing predicted approval date back to late 2018

- PMLiVE

The impact of Trump’s victory on pharma and healthcare

Donald Trump’s presidency is unlikely to leave any industry untouched. But how will pharma, biotech and healthcare fare when he takes office?

Deal Watch December 2016

Allergan, AZ, BMS, Pfizer, Roche and more feature in this month's pharma deals round-up

- PMLiVE

GLOBALHealthPR appoints Asia-Pacific lead

James Yi becomes an executive director at the health comms network

- PMLiVE

Bayer appoints head of EU liaison office

Volker Koch-Achelpöhler succeeds Bernd Halling

Eli Lilly HQ

Lilly to buy migraine drug developer CoLucid for $960m

Deal revolves around lasmiditan, which the firm out-licensed in 2005

- PMLiVE

Sobi looks to real-world trial to push Elocta take-up

Aims to show haemophilia A treatment’s benefit to reimbursement authorities

Patient-centred care innovation in dementia: a conversation with Neil Maiden

Content Marketing Manager Liz Inskip interviews Neil Maiden of City, University of London, about his work developing mobile technology solutions for residential dementia care, and what the challenges facing innovators...

Blue Latitude Health

Strategic symbionts

Strategic alliances are becoming more interesting and more important 

- PMLiVE

Tonic Life Communications expands leadership team

Appoints Stephanie DeViteri, Dana Lynch, Kelly Kutchinsky and Theresa Dolge

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links